Clinical Trial Update: China ADVATE PTP Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ADVATE in China, completed study under Baxalta/Shire sponsorship for Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ADVATE (antihemophilic factor VIII)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED